THE RESISTANCE OF MACROPHAGE-LIKE TUMOR-CELL LINES TO GROWTH-INHIBITION BY LIPOPOLYSACCHARIDE AND PERTUSSIS TOXIN

被引:13
作者
XIE, Y [1 ]
VONGAVEL, S [1 ]
CASSADY, AI [1 ]
STACEY, KJ [1 ]
DUNN, TL [1 ]
HUME, DA [1 ]
机构
[1] UNIV QUEENSLAND, CTR MOLEC BIOL & BIOTECHNOL, ST LUCIA, QLD 4072, AUSTRALIA
关键词
D O I
10.1111/j.1365-2141.1993.tb03092.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The process of tumorigenesis is frequently associated with resistance to growth inhibition by physiological regulators of normal cells. Murine macrophage-like cell lines BAC1.2F5, RAW264, J774.1A and PU5/1.8 were resistant to growth inhibition by bacterial lipopolysaccharide (LPS) and pertussis toxin, agents that blocked growth of primary bone marrow-derived macrophages (BMDM) in the presence of macrophage colony-stimulating factor (CSF-1). The resistance of the CSF-1-dependent cell line BAC1.2F5 to growth inhibition by pertussis toxin argues against the possibility that pertussis toxin-sensitive G proteins are essential for the pathway of growth stimulation by CSF-1. Conversely, these data add further weight to the argument that LPS mediates some of its biological activities by mimicking the action of pertussis toxin and inhibiting G protein function. The resistance of cell lines to LPS and pertussis toxin was not correlated with any alteration in the expression of mRNA encoding any of three pertussis-toxin sensitive G protein alpha subunits. The pattern of G protein expression was consistent between primary cells and tumour cells, suggesting that this is a differentiation marker. In particular, G(i)alpha2 mRNA was expressed at remarkably high levels in all of the cells. The specificity of LPS resistance was investigated by studying down-regulation of CSF-I binding and induction of proto-oncogene c-fos and tumour necrosis factor (TNF) mRNA. BAC1.2F5 cells were LPS-resistant in each of these assays. In CSF-1 binding, RAW2 64 and J774.1A responded in the same way as bone marrow-derived macrophages but required higher doses of LPS, whereas c-fos and TNF mRNA were induced in these cells at concentrations that did not inhibit growth. In PU5/1.8 cells, CSF-I binding was already very low and was not further down-regulated, but c-fos and TNF mRNA was inducible by LPS. By contrast to primary macrophages. the cell lines did not respond to LPS with down-regulation of c-fms mRNA, which encodes the CSF-I receptor. Hence, the resistance of macrophage-like tumour cells to LPS and pertussis toxin was specific to the pathways controlling growth, and was correlated with altered regulation of the CSF-1 receptor.
引用
收藏
页码:392 / 401
页数:10
相关论文
共 25 条
[1]   IMMUNOCHEMICAL AND ELECTROPHORETIC CHARACTERIZATION OF THE MAJOR PERTUSSIS TOXIN SUBSTRATE OF THE RAW264 MACROPHAGE CELL-LINE [J].
BACKLUND, PS ;
AKSAMIT, RR ;
UNSON, CG ;
GOLDSMITH, P ;
SPIEGEL, AM ;
MILLIGAN, G .
BIOCHEMISTRY, 1988, 27 (06) :2040-2046
[2]  
BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675
[3]   CONSTITUTIVE EXPRESSION OF THE UROKINASE PLASMINOGEN-ACTIVATOR GENE IN MURINE RAW264 MACROPHAGES INVOLVES DISTAL AND 5' NONCODING SEQUENCES THAT ARE CONSERVED BETWEEN MOUSE AND PIG [J].
CASSADY, AI ;
STACEY, KJ ;
NIMMO, KA ;
MURPHY, KM ;
VONDERAHE, D ;
PEARSON, D ;
BOTTERI, FM ;
NAGAMINE, Y ;
HUME, DA .
NUCLEIC ACIDS RESEARCH, 1991, 19 (24) :6839-6847
[4]  
CHEN BDM, 1984, J IMMUNOL, V132, P2955
[5]  
CHEN BDM, 1983, J IMMUNOL, V130, P2256
[6]   TUMOR-PROMOTING PHORBOL ESTERS INHIBIT THE BINDING OF COLONY-STIMULATING FACTOR (CSF-1) TO MURINE PERITONEAL-EXUDATE MACROPHAGES [J].
CHEN, BDM ;
LIN, HS ;
HSU, S .
JOURNAL OF CELLULAR PHYSIOLOGY, 1983, 116 (02) :207-212
[7]  
DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240
[8]   LIGAND AND PROTEIN KINASE-C DOWNMODULATE THE COLONY-STIMULATING FACTOR-I RECEPTOR BY INDEPENDENT MECHANISMS [J].
DOWNING, JR ;
ROUSSEL, MF ;
SHERR, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (07) :2890-2896
[9]   MODULATION OF RECEPTORS FOR THE COLONY-STIMULATING FACTOR, CSF-1, BY BACTERIAL LIPOPOLYSACCHARIDE AND CSF-1 [J].
GUILBERT, LJ ;
STANLEY, ER .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 73 (01) :17-28
[10]  
GUSELLA GL, 1990, J IMMUNOL, V144, P3574